• Amplex Red in High-Precision Enzyme Activity and Redox Signa

  2026-06-21

  Explore how Amplex Red enables ultra-sensitive detection of hydrogen peroxide and peroxidase activity in advanced biochemical assays. This article uniquely focuses on optimizing assay reliability and practical protocol design for redox signaling studies using this fluorogenic probe.

• Reelin-SFK Pathway: A Gatekeeper for Ketamine’s Antidepressa

  2026-06-20

  This study uncovers a critical requirement for intact Reelin-Apoer2-Src family kinase (SFK) signaling in enabling the behavioral and synaptic effects of ketamine. By employing genetic and pharmacological approaches, the authors demonstrate that disruptions in this pathway may underlie nonresponsiveness to ketamine in treatment-resistant depression, with implications for both neurobiology and future assay development.

• Blocking Extracellular Vesicle Release in Triple-Negative Br

  2026-06-19

  McNamee et al. systematically evaluated the inhibition of extracellular vesicle (EV) release in triple-negative breast cancer (TNBC) cells using several compounds, including the ROCK inhibitor Y-27632 dihydrochloride. Their findings reveal that broad suppression of EV secretion—achievable with non-toxic inhibitor regimens—significantly limits the transmission of aggressive cancer traits via EVs, underscoring the therapeutic potential of targeting EV biogenesis in TNBC.

• Trolox: Protocol Optimization for Oxidative Injury Research

  2026-06-19

  Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) is the benchmark cell-permeable antioxidant for precise oxidative injury modeling and assay calibration. This article unpacks practical workflows, advanced troubleshooting, and key protocol parameters to maximize reproducibility in neurodegeneration and cancer biology research.

• HyperScript First-Strand cDNA Synthesis Kit: Precision for C

  2026-06-18

  Unlock robust and reproducible cDNA synthesis from even the most challenging RNA templates with the HyperScript First-Strand cDNA Synthesis Kit. Its engineered reverse transcriptase enables sensitive detection of low-abundance transcripts and seamless integration into PCR and qPCR workflows, setting a new benchmark for gene expression studies.

• Topotecan (SKF104864): Translational Insights for Pediatric

  2026-06-18

  Explore Topotecan’s dual role as a topoisomerase I inhibitor and translational tool in advanced cancer research. This article unveils unique evidence-based strategies for apoptosis induction in glioma cells and pediatric solid tumor models, offering new perspectives for assay optimization.

• Mitocytosis Inhibition Enhances Mitochondria-Targeted Antime

  2026-06-17

  This study uncovers how mitocytosis—a migrasome-mediated expulsion of damaged mitochondria—limits the efficacy of mitochondria-targeted therapies in metastatic breast tumor models. By engineering a dual-targeting nanoplatform to inhibit mitocytosis and induce mitochondrial damage, the authors demonstrate significantly improved antimetastatic effects, offering a new strategy for optimizing organelle-directed drug delivery.

• Trolox: Mechanistic Insights and Advanced Applications in Ox

  2026-06-17

  Explore how Trolox, a potent cell-permeable antioxidant, advances oxidative injury research by uniquely targeting lipid peroxidation and redox signaling. This article delivers mechanistic depth and practical guidance for assay design, setting it apart from standard protocol guides.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti

  2026-06-16

  This study establishes a rapid, scalable protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons, enabling robust modeling of herpes simplex virus 1 (HSV-1) latent infection and reactivation. The platform overcomes previous limitations of human neuron availability and opens new avenues for mechanistic virology and therapeutic discovery.

• Nutlin-3a: Precision MDM2 Inhibitor for Enhanced Cancer Rese

  2026-06-16

  Nutlin-3a, a potent small-molecule MDM2 inhibitor from APExBIO, enables robust p53 pathway activation, facilitating advanced cancer research workflows. This article delivers actionable protocol guidance, troubleshooting insights, and translates mechanistic advances—such as those from recent glioblastoma studies—into optimized experimental choices.

• GSK126 EZH2 Inhibitor: Precision Tools for Cancer Epigenetic

  2026-06-15

  GSK126, a potent and selective EZH2 inhibitor, is transforming cancer epigenetics research and precision oncology workflows. This article details best practices, advanced applications, and troubleshooting strategies for leveraging GSK126—supplied by APExBIO—in studies of PRC2 function and EZH2-driven cancers.

• PreScission Protease (PSP): Mechanisms, Precision, and Advan

  2026-06-15

  Discover how PreScission Protease enables high-precision fusion protein tag cleavage with HRV 3C protease specificity. This article uniquely explores mechanistic insights, advanced assay design, and the impact of recent biomolecular research on protein purification workflows.

• Kitasamycin Efficacy and Resistance in Swine Dysentery Contr

  2026-06-14

  This study rigorously evaluated the macrolide antibiotic kitasamycin for controlling swine dysentery caused by Brachyspira hyodysenteriae in Australian pig herds. The research revealed that while kitasamycin can prevent disease in susceptible isolates, widespread resistance—mediated by 23S rRNA mutations—poses a major challenge for sustainable disease management.

• Substance P in Precision Bioaerosol Detection and Neuroimmun

  2026-06-13

  Explore how Substance P, a key tachykinin neuropeptide, is revolutionizing pain transmission research and bioaerosol detection. This article uniquely integrates technical protocol guidance with advances in spectral interference removal for robust neuroimmune assays.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research

  2026-06-12

  Hydroxychloroquine Sulfate is a synthetic quinoline derivative used to inhibit autophagy and toll-like receptor 7/9 signaling in models of autoimmune disease, including systemic lupus erythematosus and rheumatoid arthritis. It is appropriate for workflows requiring aqueous solubility and short-term solution stability but should not be used where organic solvents or long-term storage are needed.

422 records 12/29 page Previous Next First page 上5页 1112131415 下5页 Last page